Spironolactone and Hydrochlorothiazide
NDC 42292-017, spironolactone and hydrochlorothiazide, tablet, from Mylan Institutional Inc..
- Product NDC
- 42292-017
- Status
- Listed
- Labeler
- Mylan Institutional Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA086513
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42292-017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SPIRONOLACTONE25 mg/1
- HYDROCHLOROTHIAZIDE25 mg/1
Pharmacologic classes
Aldosterone Antagonist [EPC]; Aldosterone Antagonists [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42292-017-20 | 42292001720 | 100 BLISTER PACK in 1 CARTON (42292-017-20) / 1 TABLET in 1 BLISTER PACK (42292-017-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f2a4fbc0-650b-440d-9555-c1720fe0fe35NADAC price for package 42292001720
GET /v1/drugs/nadac/42292001720
Use it
Look up 42292-017 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42292-017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42292-017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.